Laurion Capital Management LP Vanda Pharmaceuticals Inc. Transaction History

Laurion Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $301,893 - $426,729	-30,900 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $287,988 - $371,418	30,900 New	30,900 $298,000
Q1 2020 May 14, 2020	SELL	$7.5 - $16.8 $111,000 - $248,640	-14,800 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$12.38 - $17.47 $238,934 - $337,171	-19,300 Reduced 56.6%	14,800 $243,000
Q3 2019 Nov 13, 2019	BUY	$12.27 - $15.79 $87,669 - $112,819	7,145 Added 26.51%	34,100 $453,000
Q2 2019 Aug 13, 2019	BUY	$13.37 - $18.85 $360,388 - $508,101	26,955 New	26,955 $380,000
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $1.25 Million - $2.08 Million	-66,111 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $1.21 Million - $1.52 Million	66,111 New	66,111 $1.52 Million
Q2 2018 Aug 13, 2018	SELL	$13.95 - $19.15 $2.71 Million - $3.72 Million	-194,070 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$14.05 - $20.2 $2.73 Million - $3.92 Million	194,070 New	194,070 $3.27 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.